Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOryx International Growth Regulatory News (OIG)

Share Price Information for Oryx International Growth (OIG)

Share Price is delayed by 15 minutes
Get Live Data
1,280.00    5.00 (0.39%)
Bid:
1,230.00
Ask:
1,305.00
Spread: 75.00 (6.098%)
Market Cap: £179.20m
OIG Live PriceLast checked at - London Stock Exchange

Intraday Oryx International Growth Share Chart

Interim Management Statement

10 Feb 2011 16:30

RNS Number : 0489B
Oryx International Growth Fund Ld
10 February 2011
 



ORYX INTERNATIONAL GROWTH FUND LIMITED

 

INTERIM MANAGEMENT STATEMENT FOR THE QUARTER ENDED 31 DECEMBER 2010

 

Oryx International Growth Fund Limited ("Oryx" or the "Company"), is publishing this Interim Management Statement in accordance with DTR 4.3 of the FSA Handbook.

 

This interim management statement has been produced solely to provide additional information to shareholders as a body to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.

 

This interim management statement relates to the period from 1 October 2010 to 31 December 2010, and contains information that covers this period, and up to the date of publication of this interim management statement, unless otherwise specified.

 

 

Manager's Review

 

The FTSE All-Share TR Index (£) returned 7.38% over the fourth quarter. Risk assets were in demand after the announcement of further quantitative easing in the United States and on the back of greater economic optimism, particularly on signs of recovery in the US economy. December was a particularly strong month for developed market equities including the UK stock market. Reflecting this increased risk appetite, the FTSE Small Cap TR Index outperformed the broad index, returning 9.05%. Against this backdrop, the Fund's NAV rose by 11.28%, while its share price advanced 20.25% to £2.375. The discount to NAV narrowed sharply from 21.72% at the start of the quarter to 15.41% at the end of December.

 

 

Material Transactions

Since 1 October 2010 the Company has purchased for cancellation the following shares:

 

12 November 2010 a total of 15,000 ordinary shares at a gross price of £2.10 per share.

19 November 2010 a total of 15,000 ordinary shares at a gross price of £2.10 per share.

10 December 2010 a total of 37,860 ordinary shares at a gross price of £2.15 per share.

 

 

Material Events

There were no material events during the quarter ended 31 December 2010.

 

 

Report and Accounts

On 11 November 2010, the Company posted its Interim Report for the six months ended 30 September 2010, to Shareholders.

 

 

Financial Highlights

 

 

31 December 2010

30 June 2010

31 March 2010

31 December 2009

 

 

 

 

 

NAV

£2.81

£2.35

£2.28

£2.26

 

 

 

 

 

US Dollar / Sterling Exchange Rate

 

1.5657

 

1.4961

 

1.5169

 

1.4378

 

 

 

 

 

 

 

Twenty Largest Equity Investments at 31 December 2010

 

%

Chrysalis Group Plc

9.66

Gleeson (M J) Group Plc

6.89

BBA Aviation Plc

6.71

CVS Group Plc

5.78

RPC Group Plc

5.25

Idox Plc

4.84

Quarto Group Inc

4.79

Catalyst Media Group Plc

4.46

Orthoproducts Ltd

4.41

Bavaria Industriekapital AG

4.30

Journey Group Plc

4.03

IS Pharma Plc

3.90

Phoenix Group Holdings

3.18

Augean

3.01

Innovation Group Plc

2.85

Focus Solutions Group Plc

2.76

Vislink Plc

2.63

Nastor Inv Ltd Zero Dividend Preference Shares

2.52

Assetco Plc

2.30

RPC Group Plc nrp rts 21/01/2011

1.93

% of total portfolio

86.20

 

The financial information for the quarter ended 31 December 2010 contained within this Interim Management Statement has not been audited.

 

 

By order of the Board

 

 

 

 

BNP Paribas Fund Services (Guernsey) Limited, for and on behalf of

Oryx International Growth Fund Limited

as Company Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGGUAPPUPGGQU
Date   Source Headline
4th Jun 20264:56 pmRNSNet Asset Value(s)
1st Jun 20265:03 pmRNSNet Asset Value(s)
26th May 20264:26 pmRNSNet Asset Value(s)
18th May 20265:17 pmRNSNet Asset Value(s)
11th May 20264:46 pmRNSNet Asset Value(s)
11th May 20267:53 amRNSNet Asset Value(s)
7th May 20267:00 amRNSWeekly Net Asset Value Reporting
21st Apr 202610:00 amRNSDirector/PDMR Shareholding
20th Apr 20269:43 amRNSDirector/PDMR Shareholding
16th Apr 20269:37 amRNSProposed acquisition of Animalcare Group Plc
13th Apr 20262:16 pmRNSDirector/PDMR Shareholding
13th Apr 20262:05 pmRNSDirector/PDMR Shareholding
13th Apr 20262:00 pmRNSDirector/PDMR Shareholding
13th Apr 20262:00 pmRNSDirector/PDMR Shareholding
13th Apr 20261:55 pmRNSDirector/PDMR Shareholding
10th Apr 20264:48 pmRNSNet Asset Value(s)
27th Mar 20267:00 amRNSAppointment of new Chairman
23rd Mar 202610:29 amRNSPassing of the Chairman
9th Mar 202611:19 amRNSNet Asset Value(s)
11th Feb 202610:37 amRNSEGM Requisition
9th Feb 20269:08 amRNSNet Asset Value(s)
3rd Feb 20261:46 pmRNSNet Asset Update
30th Jan 202610:02 amRNSPotential Bid for Pinewood Technologies Group Plc
22nd Jan 20269:40 amRNSBid for Kitwave Plc
9th Jan 20264:31 pmRNSNet Asset Value(s)
10th Dec 20257:00 amRNSHalf-year Financial Report
8th Dec 202510:55 amRNSNet Asset Value(s)
10th Nov 20253:40 pmRNSNet Asset Value(s)
9th Oct 20253:13 pmRNSNet Asset Value(s)
18th Sep 20251:47 pmRNSChange of Corporate Broker
9th Sep 20257:00 amRNSInvestor Presentation
8th Sep 202511:15 amRNSNet Asset Value(s)
20th Aug 202511:03 amRNSResult of AGM
8th Aug 202512:22 pmRNSNet Asset Value(s)
23rd Jul 20254:13 pmRNSNotice of AGM
10th Jul 202512:06 pmRNSDirector/PDMR Shareholding
9th Jul 20251:54 pmRNSNet Asset Value(s)
7th Jul 20257:00 amRNSAnnual Financial Report
10th Jun 202512:16 pmRNSNet Asset Value(s)
4th Jun 20254:18 pmRNSDirector/PDMR Shareholding
12th May 20251:12 pmRNSNet Asset Value(s)
11th Apr 20255:11 pmRNSDirector/PDMR Shareholding
11th Apr 20255:11 pmRNSDirector/PDMR Shareholding
8th Apr 20252:41 pmRNSNet Asset Value(s)
18th Mar 20259:22 amRNSDirector/PDMR Shareholding
10th Mar 20255:56 pmRNSNet Asset Value(s)
17th Feb 20253:45 pmRNSDirector/PDMR Shareholding
10th Feb 202511:35 amRNSNet Asset Value(s)
4th Feb 20253:07 pmRNSDirector/PDMR Shareholding
20th Jan 20254:53 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.